These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


435 related items for PubMed ID: 18420514

  • 21. To have (medical devices) or not: what's safer for patients?
    McCormack J.
    Health Facil Manage; 1995 Jun; 8(6):44, 46, 48. PubMed ID: 10142630
    [No Abstract] [Full Text] [Related]

  • 22. Pharmaceuticals and medical devices: medical devices. Year end issue brief.
    Tiffany S.
    Issue Brief Health Policy Track Serv; 2008 Jan 07; ():1-19. PubMed ID: 18345548
    [No Abstract] [Full Text] [Related]

  • 23. Post-decision diagnosis: medical device preemption alive and mostly well after Medtronic, Inc. v. Lohr.
    Sayler SW, Thomas SM.
    Ann Health Law; 1997 Jan 07; 6():185-208. PubMed ID: 10184786
    [Abstract] [Full Text] [Related]

  • 24. The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices.
    Mottes LM.
    Seton Hall Law Rev; 2011 Jan 07; 41(2):723-63. PubMed ID: 21739761
    [No Abstract] [Full Text] [Related]

  • 25. Modernizing device regulation.
    Samp RA.
    N Engl J Med; 2010 Jul 08; 363(2):196; author reply 197. PubMed ID: 20647219
    [No Abstract] [Full Text] [Related]

  • 26. Challenging the viability of FDCA-based causes of action in the tort context: the orthopedic bone screw experience.
    Beck JM, Valentine JA.
    Food Drug Law J; 2000 Jul 08; 55(3):389-433. PubMed ID: 11824467
    [No Abstract] [Full Text] [Related]

  • 27. Watchdog group says "massive lobbying effort" by medical device industry threatens public health.
    Lenzer J.
    BMJ; 2012 Feb 28; 344():e1521. PubMed ID: 22374926
    [No Abstract] [Full Text] [Related]

  • 28. Good law from tragic facts--Congress, the FDA, and preemption.
    Annas GJ.
    N Engl J Med; 2009 Sep 17; 361(12):1206-11. PubMed ID: 19759383
    [No Abstract] [Full Text] [Related]

  • 29. King v. Collagen Corporation: FDA approval insulates medical device manufacturers from state common law liability.
    Kronenberg AW.
    J Contemp Health Law Policy; 1995 Sep 17; 11(2):563-87. PubMed ID: 10184353
    [No Abstract] [Full Text] [Related]

  • 30. PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
    Flaherty JM.
    Food Drug Law J; 2001 Sep 17; 56(3):339-49. PubMed ID: 11944643
    [No Abstract] [Full Text] [Related]

  • 31. The Supreme Court, preemption, and malpractice liability.
    Kesselheim AS, Studdert DM.
    N Engl J Med; 2009 Feb 05; 360(6):559-61. PubMed ID: 19196672
    [No Abstract] [Full Text] [Related]

  • 32. Guide to preemption of state-law claims against Class III PMA medical devices.
    Whitney DW.
    Food Drug Law J; 2010 Feb 05; 65(1):113-39, ii-iii. PubMed ID: 24475536
    [Abstract] [Full Text] [Related]

  • 33. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT.
    Food Drug Law J; 2007 Feb 05; 62(3):559-72. PubMed ID: 17915397
    [No Abstract] [Full Text] [Related]

  • 34. Pharmaceuticals and medical devices: medical devices.
    Health Policy Tracking Service, a service of Thomson Reuters Accelus, Berry MD.
    Issue Brief Health Policy Track Serv; 2012 Jan 03; ():1-38. PubMed ID: 22403842
    [No Abstract] [Full Text] [Related]

  • 35. Remarks by the Commissioner of Food and Drugs at the twentieth anniversary celebration of the 1976 Medical Device Amendments.
    Kessler DA.
    Food Drug Law J; 1996 Jan 03; 51(4):501-3. PubMed ID: 11797727
    [No Abstract] [Full Text] [Related]

  • 36. Recent legal developments affecting medical device manufacturers.
    Lough MH.
    Healthspan; 1993 Sep 03; 10(8):21-3. PubMed ID: 10129148
    [No Abstract] [Full Text] [Related]

  • 37. A strike against preemption.
    Nat Biotechnol; 2009 May 03; 27(5):397. PubMed ID: 19430422
    [Abstract] [Full Text] [Related]

  • 38. Remarks by the Honorable Paul Rogers at the twentieth anniversary celebration of the 1976 Medical Device Amendments.
    Rogers PG.
    Food Drug Law J; 1996 May 03; 51(4):505-7. PubMed ID: 11797728
    [No Abstract] [Full Text] [Related]

  • 39. Judicial review of FDA preemption determinations.
    Frost A.
    Food Drug Law J; 1999 May 03; 54(3):367-88. PubMed ID: 11797704
    [No Abstract] [Full Text] [Related]

  • 40. The FDA defense: a prescription for easing the pain of punitive damage awards in medical products liability cases.
    Marthaler AL.
    Spec Law Dig Health Care Law; 1997 Sep 03; (223):9-45. PubMed ID: 10173273
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.